GCP
MBOT icon

GSA Capital Partners’s Microbot Medical MBOT Stock Holding History

GSA Capital Partners’s Portfolio MBOT Stock Details MBOT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-7
Closed -$12K – 2084
2015
Q1 		$12K Hold
7
– – ﹤0.01% 2080
2014
Q4 		$11K Buy
+7
New +$12.7K ﹤0.01% 1654

Other funds holding MBOT

BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BCM
Bourgeon Capital Management Darien, Connecticut $578M AUM 41.69% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

GSA Capital Partners's MBOT Position: Q2 2015 in Review

GSA Capital Partners sold out of Microbot Medical (MBOT) in Q2 2015, closing a stake of 7 shares — an estimated $12K sold.

GSA Capital Partners first reported a position in MBOT in Q4 2014 and held it in 2 quarters. The position peaked at $12K in Q1 2015. 30 funds tracked by Wall St. Rank hold MBOT as of Q2 2015.

  • GSA Capital Partners reported no remaining Microbot Medical position as of Q2 2015 after selling out during the quarter.
  • GSA Capital Partners sold 7 Microbot Medical shares in Q2 2015, an estimated $12K.
  • GSA Capital Partners first reported a position in Microbot Medical in Q4 2014 and held it in 2 quarters.
  • GSA Capital Partners's Microbot Medical position peaked at $12K in Q1 2015.
  • 30 funds tracked by Wall St. Rank held Microbot Medical as of Q2 2015.

Based on GSA Capital Partners's 13F filing for Q2 2015, filed 14 Aug 2015.